A cautious culture cost Novo Nordisk its lead in the obesity drug race, former employees say While first out of the gate, the maker of Wegovy is now playing catch-up to rival Eli Lilly

https://www.statnews.com/2025/06/05/novo-nordisk-weight-loss-drugs-market-dominance-slips-eli-lilly-gains-here-is-why/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-_6qLZr2FVQrJlQr7kYE7mM4RlTanaMGgXktlEO1AIsZ_lhwUl8wsEwga3OR2MOQ8LMXoxux0v8lKVWzam544kxFbm6RA&_hsmi=365023293&utm_content=365023293&utm_source=hs_email